Polymerase chain reaction-proved herpes simplex encephalitis in children

Herpes simplex encephalitis (HSE) remains a critical cause of severe neurological outcomes in children. Prior research has shown that HSE can lead to high mortality and morbidity, particularly in younger patients. However, specific clinical features that distinguish HSE from other central nervous system infections remain unclear. While PCR has improved diagnostic accuracy, the role of clinical presentation and ancillary tests in confirming HSE is still debated. It was already known that HSE often presents with non-specific symptoms such as fever and seizures. No prior work had resolved whether neuroimaging or electroencephalography findings reliably distinguish HSE from other infections. This gap motivated a study to compare clinical and diagnostic features of PCR-confirmed HSE with non-HSE cases. The study aimed to clarify whether specific diagnostic tools or clinical parameters could reliably identify HSE in children.

The aim of this study was to evaluate clinical and diagnostic characteristics of children with PCR-confirmed HSE compared to those with other central nervous system infections. The researchers sought to determine whether specific clinical features, neuroimaging findings, or electroencephalography patterns could reliably distinguish HSE from non-HSE cases. They also aimed to assess factors influencing morbidity and mortality in HSE patients. The motivation stemmed from the lack of clear clinical markers for HSE diagnosis. By comparing 24 HSE cases with 38 non-HSE cases, the study aimed to identify patterns that could guide early diagnosis. The researchers proposed that neuroimaging and electroencephalography might offer diagnostic clues. This approach was chosen to address the diagnostic uncertainty in HSE cases. The study sought to clarify the role of ancillary tests in confirming HSE in children.

The study compared clinical and laboratory findings from 24 children with PCR-confirmed HSE and 38 children with non-HSE central nervous system infections. Researchers collected data on fever, seizures, initial neurological symptoms, and consciousness levels. They analyzed cerebrospinal fluid for cell count, protein, and glucose. Neuroimaging via computerized tomography was performed on all patients. Electroencephalography was used to detect periodic lateralized epileptiform discharges. Glasgow Coma Scale scores were recorded to assess severity. Age was noted as a potential prognostic factor. Outcomes such as mortality and sequelae were compared between groups.

Computerized tomography showed localized brain abnormalities in 75% of HSE patients versus 31% of non-HSE patients (P = 0.001). Electroencephalography detected periodic lateralized epileptiform discharges in 36% of HSE patients but none in non-HSE patients (P = 0.0001). No significant differences were found in fever, seizures, consciousness, or cerebrospinal fluid parameters. Mortality and severe morbidity rates were higher in HSE patients. All HSE patients with a Glasgow Coma Scale score of 11 or above fully recovered. Younger HSE patients (under 3 years) had higher risk of severe outcomes (P = 0.02). Neuroimaging and electroencephalography findings were more frequent in HSE but not diagnostic on their own. Clinical features alone could not distinguish HSE from other infections.

The authors propose that HSE lacks specific clinical features that distinguish it from other central nervous system infections. Neuroimaging and electroencephalography findings were more common in HSE patients but not diagnostic alone. The Glasgow Coma Scale score and age were significant predictors of outcome in HSE cases. The study suggests that PCR remains the most reliable method for confirming HSE. Younger children with HSE face higher risks of severe outcomes. The researchers suggest that neuroimaging and electroencephalography may support but not confirm HSE diagnosis. They propose that clinical presentation alone is insufficient for diagnosing HSE. These findings emphasize the importance of PCR testing in suspected HSE cases.